The results indicated that the Bio-MnO2 NPs not only relieved tumor hypoxia so as to augment the efficacy of RT, but also synergistically enhanced the cGAS-STING activity to activate radioimmune responses, boosting ICD while increasing CTLs infiltration. The gene discussed is STING1; the disease is neoplasm.